文献速递炎症性肠病

粪菌移植中的菌株定植与克罗恩病缓解维持的关联

Linking Strain Engraftment in Fecal Microbiota Transplantation With Maintenance of Remission in Crohn's Disease.
PubMed 文献 · Gastroenterology · 2020-08-26

该研究对处于缓解期的克罗恩病患者进行粪菌移植前后的粪便宏基因组分析,在物种和菌株水平评估微生物组变化。发现粪菌移植对患者微生物组成有显著长期影响,主要由供体菌种低丰度定植驱动,38%的粪菌移植驱动变化为菌株替换。部分放线菌门定植和变形菌门定植或丢失与更好的疾病结局相关,而拟杆菌门传播则有害。

要点

  • 粪菌移植对克罗恩病患者微生物组成有显著长期影响,主要由供体菌种低丰度定植驱动。
  • 38%的粪菌移植驱动变化为菌株替换,强调宏基因组学详细分析的重要性。
  • 放线菌门定植及变形菌门定植或丢失与更好结局相关,拟杆菌门传播有害。

核心结论

  • 结果提示某些进化支可能通过粪菌移植有益于传播或消除,并提供可能有助于识别个性化粪菌移植供体以更有效维持克罗恩病缓解的标准。

研究设计与样本

  • 从处于缓解期的克罗恩病患者获取粪便宏基因组,在粪菌移植前后于物种和菌株水平评估肠道微生物组组成,并进行纵向随访评估。

主要发现

  • 粪菌移植对患者微生物组成有显著长期影响,但主要由供体菌种定植驱动且保持低丰度。
  • 38%的粪菌移植驱动变化为菌株替换。
  • 观察到供体与患者菌株长期共存的多个实例。
  • 部分放线菌门定植以及变形菌门定植或丢失与接受粪菌移植的克罗恩病患者更好的疾病结局相关。
  • 拟杆菌门传播有害。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Crohn's disease (CD) is a chronic gastrointestinal disease resulting from the dysfunctional interplay between genetic susceptibility, the immune system, and commensal intestinal microbiota. Emerging evidence suggests that treatment by suppression of the immune response and replacement of the microbiota through fecal microbiota transplantation (FMT) is a promising approach for the treatment of CD. METHODS: We obtained stool metagenomes from CD patients in remission and assessed gut microbiome composition before and after FMT at the species and strain levels. Longitudinal follow-up evaluation allowed us to identify the gain, loss, and strain replacement of specific species and link these events to the maintenance of remission in CD. RESULTS: We found that FMT had a significant long-term effect on patient microbial compositions, although this was primarily driven by the engraftment of donor species, which remained at low abundance. Thirty-eight percent of FMT-driven changes were strain replacements, emphasizing the importance of detailed profiling methods, such as metagenomics. Several instances of long-term coexistence between donor and patient strains were also observed. Engraftment of some Actinobacteria, and engraftment or loss of Proteobacteria, were related to better disease outcomes in CD patients who received FMT, and transmission of Bacteroidetes was deleterious. CONCLUSIONS: Our results suggest clades that may be beneficial to transmit/eliminate through FMT, and provide criteria that may help identify personalized FMT donors to more effectively maintain remission in CD patients. The framework established here creates a foundation for future studies centered around the application of FMT and defined microbial communities as a therapeutic approach for treating CD.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Kong L, Lloyd-Price J, Vatanen T, et al. Linking Strain Engraftment in Fecal Microbiota Transplantation With Maintenance of Remission in Crohn's Disease. Gastroenterology. 2020. PMID: 32860788. doi:10.1053/j.gastro.2020.08.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。